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Abstract
We have previously demonstrated by FACS analysis and
histochemistry that Fas ligand (FasL) increases on co-
chlear cell surfaces after immune response or stimula-
tion with Á-interferon (IFN-Á). To determine whether the
appearance of FasL on cochlear cell membranes is relat-
ed to gene expression or to posttranslational events, co-
chlear cells were treated with IFN-Á. They were evaluated
for FasL gene expression by real-time PCR and for FasL
protein localization by confocal microscopy of perme-
abilized and immunolabeled cells. Real-time PCR analy-
sis of cDNAs generated from unstimulated or IFN-Á-stim-
ulated organ of Corti demonstrated no change in the
transcription of the gene encoding FasL. In contrast, con-
focal microscopy revealed dramatic changes in the cellu-
lar distribution of FasL, consistent with movement from
the endoplasmic reticulum to the cytoplasm and cell
membrane. The results suggest that recruitment of pre-
formed FasL from intracellular compartments, rather
than its biosynthesis, is responsible for the increase in
FasL on the cell surface following IFN-Á stimulation. This
is similar to the response of cytotoxic T lymphocytes in
which gene expression is not involved in FasL surface
appearance. Presumably, the use of preformed FasL
increases the rapidity of this response. FasL localization
to the membrane may be involved in protecting the inner
ear from autoimmunity or inflammation. Alternatively it
may be related to cochlear cell death in response to
inflammatory stress.
Copyright © 2003 S. Karger AG, Basel
Introduction
Apoptosis, or programmed cell death, selectively tar-
gets certain cells to undergo cell death following distinct
biological signals. It plays an important role in develop-
ment and tissue homeostasis [Zimmermann et al., 2001].
In general, there are two intracellular pathways leading to
apoptosis, an intrinsic and an extrinsic pathway. In the
intrinsic pathway, mitochondria release apoptogenic fac-
tors into the cytoplasm, which then activate the down-
stream execution phase of apoptosis [Kluck et al., 1997].
In the extrinsic pathway, death receptors such as Fas and
TNFR1 initiate apoptosis upon ligand binding. Apoptotic
cell death mediated by Fas is widespread in the immune
system, where it serves in the deletion of activated periph-
eral lymphocytes [Nagata and Golstein, 1995].
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The Fas and Fas ligand (FasL) system was initially
identified because of its involvement in the regulation of
apoptosis in the immune system [Nagata and Golstein,
1995]. FasL is a trimeric type II membrane protein of
approximately 37 kD [Suda et al., 1993]. When FasL
binds to its receptor Fas, caspases are activated and the
cell typically dies by apoptosis [Nagata and Golstein,
1995]. The Fas receptor is expressed on many cell types,
including most inflammatory cells. However, as might be
expected for a death ligand, the display of FasL on the cell
surface is tightly regulated. This molecule is expressed on
immune cells such as activated T cells [Suda et al., 1995],
natural killer cells [Oshimi et al., 1996] as well as on non-
immune cells such as cells in the corneal epithelium and
the retina in the eye [Griffith et al., 1996] and Sertoli cells
in the testis [Bellgrau et al., 1995]. FasL can also be
expressed on the cell surface of other cell types in response
to tissue damage and inflammation.
Recently, we have demonstrated by FACS analysis and
immunohistochemistry that FasL on the surface of co-
chlear cells increases after stimulation with Á-interferon
(IFN-Á) or after the induction of a sterile labyrinthitis
[Bodmer et al., 2002]. It may be involved in the defense of
inner ear tissue from inflammation and immunity, as has
been suggested for the anterior chamber of the eye [Grif-
fith et al., 1996]. In the present study, we explored the
mechanisms by which cells of the organ of Corti (OC)
increase the level of FasL after stimulation with IFN-Á.
We employed real-time PCR, a highly sensitive method,
to quantify cDNA produced by reverse transcription of
mRNA from OC stimulated with IFN-Á. We also used
confocal microscopy to localize FasL in isolated, perme-
abilized cochlear cells.
Material and Methods
Animals and Dissection
All animal procedures have been carried out according to NIH
guidelines and followed an approved animal research protocol (VA
Medical Center, La Jolla, Calif., USA). The entire OC was dissected
from postnatal day 5 Sprague-Dawley rats according to the descrip-
tion of others [Van de Water and Ruben, 1971, 1974; Sobkowicz et
al., 1993].
Cell Culture
The cultures were maintained in Dulbecco’s modified Eagle
medium with 10% fetal bovine serum, 25 mM Hepes buffer and
30 U/ml penicillin for 24 h. Two OC were pooled per well, and in the
experimental group, the OC were stimulated with 100 IU/ml of
recombinant rat IFN-Á (R&D Systems Inc., USA) for 12 h, which was
repeated for an additional hour just prior to mRNA extraction. Con-
trol explants remained in culture medium alone.
RNA Isolation
The mRNA was isolated using oligo-dT magnetic microbeads
(Dyna-beads; Dynal) as previously described [Housley et al., 1995].
The mRNA was released from the beads by incubation in 10 mM
Tris-HCl buffer (pH 7.5) at 80°C for 5 min. First-strand cDNA syn-
thesis was performed using the superscript preamp System (Gibco-
BRL) and primed with oligo-dT.
PCR Standardization
PCR to produce a FasL DNA standard was performed using
primers specific for FasL: FasL sense primer, 5)-GACCACAAGG-
TCCAACAGG-3); FasL antisense primer, 5)-GACATCATTGCAC-
TGGAGG-3). PCR was performed at 94 °C for 3 min followed by 45
cycles of amplification. Each cycle consisted of 1 min denaturation at
94°C, 1 min of annealing at 55°C and 1 min for enzymatic primer
extension at 72 °C. After the final cycle, the temperature was held at
72°C for 7 min to allow re-annealing of the amplified products. The
PCR product was size-fractionated through a 1.5% agarose gel, and
the bands were visualized with the use of ethidium bromide. The
DNA was isolated (Gel Extraction Kit, Qiagen) and cloned into the
pCR-II Topo vector (Topo-TA-Kit; Invitrogen). Subsequent se-
quencing revealed the expected sequence of the FasL fragment
(BLAST). PCR to produce a ß-actin standard (primer set provided by
Ambion, USA) had the following conditions: 94°C for 3 min fol-
lowed by 35 cycles of amplification. Each cycle consisted of 1 min of
denaturation at 94°C, 1 min of annealing at 60°C and 1 min for
enzymatic primer extension at 72 °C. After the final cycle, the tem-
perature was held at 72°C for 7 min to allow re-annealing of the
amplified products. The ß-actin product was cloned and sequenced
as above.
Real-Time PCR
The samples were then analyzed by real-time PCR on the Smart
Cycler TD (Cepheid, Calif., USA) using the Light Cycler-FastStart
DNA Master SYBR Green I kit (Roche, USA). The real-time PCR
reaction mixture contained 1 Ìl of the sample and 24 Ìl of a master
mix containing 2 Ìl MgCl (25 mM ), 0.25 Ìl FasL forward and reverse
primers (10 ÌM ) or 0.5 Ìl ß-actin primer pair (5 ÌM ), 19.5 Ìl water
and 2 Ìl PCR core reagent (1a and 1b). Each of the 10 control and 10
experimental samples was analyzed twice with the FasL and twice
with the ß-actin primer sets. Each real-time PCR run consisted of 45
cycles. For FasL primers, each cycle consisted of 30 s of denaturation
at 95 °C, 40 s of annealing at 66°C and 40 s for enzymatic primer
extension at 72°C. For ß-actin primers, each cycle consisted of 20 s
of denaturation at 95°C, 30 s of annealing at 59°C and 30 s for enzy-
matic primer extension at 72°C.
In each run, 6 standard samples were included in the analysis.
Standard DNA was generated from the ß-actin and FasL PCR-II
clones, and the amount of DNA was quantified by measuring the
absorbance at 280 nm. For determining the FasL cDNA concentra-
tion in the samples, the following standard concentrations were used:
10, 5, 1, 0.5, 0.1 and 0 fg/Ìl. To measure ß-actin cDNA concentration
in the samples, the following standard concentrations were used:
1000, 100, 10, 1, 0.1 and 0 fg/Ìl.
For each PCR cycle, generation of the PCR product was mea-
sured by determining the fluorescence of Cybergreen, an intercalat-
ing dye that exhibits greatly increased fluorescence when bound to
double-stranded DNA, in arbitrary units referenced to an internal
standard. This resulted in an amplification curve that, if only a single
product was amplified, exhibited a smooth S-shaped, or ogival, func-
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tion. The threshold cycle was defined by taking the second derivative
of the amplification curve and determining the point of maximum
change in DNA amount from the peak of the second derivative func-
tion. This method is less sensitive to background fluorescence than
designating an arbitrary fluorescence level as the threshold. How-
ever, utilization of arbitrary threshold was also performed. This had
no significant influence on the data nor did it change the outcome.
The PCR cycle thresholds obtained with the different concentra-
tions of the standard were used to generate a standard curve for each
PCR run. The amount of FasL and ß-actin cDNA in each sample was
determined by fitting the values to the respective standard curve.
Some of the FasL levels detected in the samples were slightly lower
than in the standards used. However, since all the standards closely
followed a linear relationship, it was felt that these values were valid.
Finally, the concentration of FasL cDNA was normalized using the
concentration of ß-actin cDNA to control for any possible differences
in sample size. The relative concentration of FasL cDNA in the stim-
ulated samples was compared to the relative concentration of cDNA
in the unstimulated samples and statistically analyzed using the non-
parametric Mann-Whitney U test.
FasL Immunohistochemistry
The OC was dissected and cultured as described above. Each of
the tissue samples was immediately transferred into the well of a 48-
well tissue culture plate (Costar) in Dulbecco phosphate-buffered
saline (Gibco). Four explants were pooled per well. In order to obtain
a single cell suspension, explants were digested with 2 mg/ml trypsin,
2 mg/ml collagenase and 1.2 mg/ml elastase (Sigma, St. Louis, Mo.,
USA) for 40 min at 37°C. After removal of the supernatant, 500 Ìl
PBS containing 5% fetal calf serum, Hepes buffer 0.025 M and peni-
cillin 30 U/ml was added per well. Cell dispersion was accomplished
by trituration using a 1-ml syringe. Each respective cell population
was split into two. One aliquot was stimulated with 100 IU/ml
recombinant rat IFN-Á (R&D Systems Inc.) for 12 h, which was
repeated 1 h before fixation. The other aliquot remained unstimulat-
ed.
At the end of the culturing period, the cells were fixed with 4%
paraformaldehyde and permeabilized with 5% Triton X-100 in PBS
with 10% fetal bovine serum for 30 min. The cells were washed twice
with PBS and incubated for 30 min at 37°C with a polyclonal goat
antimouse FasL antibody (1:100, Santa Cruz Biotechnology, USA).
The cells were washed twice with PBS and incubated for 45 min at
4°C with a rabbit antigoat IgG FITC-conjugated antibody (1:100,
Jackson Immuno Inc., USA). Cells were again washed twice in PBS
and then visualized on a confocal microscope (Carl Zeiss, Germany)
with a green filter (for the FITC staining, excitation/emission wave-
length 490 nm/525 nm). The primary antibody was replaced with
PBS as a control for nonspecific binding.
Results
FasL mRNA Does Not Increase with IFN-Á Treatment
We analyzed the expression of FasL along with expres-
sion of ß-actin in OC maintained in culture medium or
stimulated with IFN-Á, using reverse transcription and
subsequent real-time PCR analysis. Analysis of the PCR
products on a 1.5% agarose gel revealed the expected size
Fig. 1. Agarose gel electrophoresis of several representative OC sam-
ples after real-time PCR. A single band of the expected size is
observed for ß-actin (294 bp) (a) and for FasL (496 bp) (b). N = Neg-
ative control (no cDNA); S = standard (0.1 fg/Ìl, the lowest DNA
concentration used); – = unstimulated OC; + = IFN-Á-stimulated
OC.
of the ß-actin (294 bp) and FasL (496 bp) fragments,
respectively. There were no primer dimers (fig. 1), which
could interfere with the determination of the concentra-
tion by real-time PCR based on Cybergreen incorpora-
tion. In addition, melting curve analysis for all real-time
PCR runs demonstrated a single peak, which is consistent
with the measurement of only a single, specific PCR prod-
uct (data not shown). PCR of all samples generated a
smooth, S-shaped growth function of fluorescence (fig. 2),
also consistent with a single PCR product.
Real-time PCR of the DNA standards (n = 6) gener-
ated a linear relationship between PCR threshold and log
concentration (fig. 2, 3). This allowed the generation of
standard curves, from which the concentration of the
samples could be determined. The ß-actin and FasL
cDNA concentrations showed only minor variation
among the samples of each group. The average cDNA
concentration of ß-actin in the unstimulated group was 49
(B15) fg/Ìl and in the stimulated group 58 (B25) fg/Ìl.
The average cDNA concentration of FasL was 0.079
(B0.01) fg/Ìl in the unstimulated and 0.085 (B0.02) fg/Ìl
in the stimulated group. There was no significant effect of
IFN-Á on either ß-actin or FasL cDNA levels.
FasL expression levels were then normalized to ß-actin
expression levels to control for differences in tissue sample
size again; in the IFN-Á-stimulated group (n = 10), the level
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Fig. 2. Cybergreen fluorescence observed across PCR amplification cycles for representative DNA standards and
IFN-Á-stimulated OC cDNA samples for ß-actin (a, b) and FasL (c, d). The vertical line for each curve identifies the
cycle value at which the highest rate of change of the initial rise in fluorescence, derived from the second derivative of
the illustrated fluorescence function, is observed. This point which is defined as the threshold cycle, is used to com-
pare across amplification curves. The ß-actin standard concentrations (a) were 1000, 100, 10, 1, 0.1 and 0 fg/Ìl. The
FasL standard concentrations (c) were 10, 5, 1, 0.5, 0.1 and 0 fg/Ìl. All curves are smooth, ogival functions, consistent
with amplification of a single product.
of FasL was not significantly different (p = 0.9), when
compared to the unstimulated group (n = 10, fig. 4).
Subcellular Localization of FasL Protein Changes with
IFN-Á Treatment
Control OC cells showed dense intracellular concentra-
tions of FasL immunostaining, confined to the perinu-
clear regions of the cells. There was no generalized stain-
ing of the cells, as would be expected with membrane
localization (fig. 5a). Cells exposed to IFN-Á for 13 h
showed a very different pattern of immunolabeling. Peri-
nuclear labeling was much less intense, and clumping was
not observed. The label was distributed more uniformly
throughout the cells, even to thin processes. It was also
observed over the cell nuclei, and in some cases a uniform
label obscured the cell nucleus (fig. 5b).
Discussion
In the present study, we found extremely low levels of
FasL transcripts in cDNAs from OC cells, compared to
ß-actin sequences. This suggests that the level of transcrip-
tion of the FasL gene is also low, or that the FasL message
is unstable, either of which possibility would lead to low
levels of protein translation. Moreover, there was no
increase in FasL transcripts and/or mRNA stability in the
OC after IFN-Á stimulation. This result suggests that the
increases in FasL that we previously observed on cochlear
cells exposed to inflammatory stimulation [Bodmer et al.,
2002] are not related to changes in gene transcription. It
further suggests the possible presence of preformed FasL
in normal cochlear cells, protein that is sequestered from
FACS and standard cytochemical analysis.
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Fig. 3. cDNA concentrations, derived from standard and OC sample amplification curves, plotted against threshold
cycle, for ß-actin (a, b) and FasL (c, d). Standard thresholds represented by circles were used to generate the best fit
function. The points fall close to the best-fit straight lines throughout the cycle range, as indicated by the correlation
coefficient of each plot. The sample values are represented by squares and were fit to the straight lines to determine
their value. The points represented in b and d were generated from the cycle threshold data in figure 2.
Fig. 4. Relative expression of FasL, cor-
rected by ß-actin expression, in the unstimu-
lated and IFN-Á-stimulated OC. Bars indi-
cate standard errors of the mean. Analysis by
Mann-Whitney U test indicated no signifi-
cant difference in cDNA ratio between the
two conditions (p = 0.9).
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Fig. 5. Confocal immunocytochemistry illustrating subcellular localization of FasL protein in dissociated cells from
the OC. a Unstimulated OC cells. These cells showed intracellular concentrations of FasL immunostaining, especially
in the perinuclear region of the cell (arrow), but no generalized staining of the cell or cell membrane. b OC cells
stimulated with IFN-Á for 13 h. These cells showed less staining of the perinuclear region and strong staining through-
out the cell (arrow).
To assess this possibility, we evaluated the cellular dis-
tribution of FasL, in cells that were dispersed and exten-
sively permeabilized to expose intracellular proteins, by
confocal microscopy. Using this method, we found in-
tense, clumped FasL immunoreactivity in the perinuclear
region of unstimulated OC cells. This is consistent with
FasL being tightly sequestered in intracellular compart-
ments such as the endoplasmic reticulum, Golgi appara-
tus or storage vesicles. After IFN-Á stimulation, immuno-
reactivity in the perinuclear regions was reduced, and
labeling was widely distributed, in OC cells. The pattern
of labeling was consistent with cytoplasmic and/or mem-
brane distribution of FasL.
This finding is in agreement with results obtained from
studies on cytotoxic T lymphocytes, where it has been
demonstrated that expression of FasL on the cell surface
of activated lymphocytes was blocked by brefeldin A, an
inhibitor of intracellular protein transport, but not by pro-
tein synthesis inhibition [Li et al., 1998]. In addition,
avoiding biosynthesis and having enough protein stored
makes it possible for a cell to respond very quickly to
extracellular stimuli.
It should be noted that OC cells were exposed to IFN-Á
for a total of 13 h and that the last addition of IFN-Á was
1 h before mRNA isolation. Therefore, it is possible that
FasL transcription occurred prior to or after the period
tested. However, we showed in a time course study using
FACS analysis that IFN-Á-stimulated FasL appeared on
the cell surface after 6 h of stimulation, with maximal sur-
face expression observed after 48 h of stimulation [Bod-
mer et al., 2002]. In this prior study, we stimulated the OC
every 12 h with IFN-Á. This makes it likely that we would
have seen an increase in gene expression after 13 h, if the
FasL increase seen by FACS was due to upregulated gene
transcription. We noted levels of variability in ß-actin
cDNAs that were about twice as great as those measured
for FasL. This may represent a technical difficulty. How-
ever, it is also possible that the FasL message is more
tightly regulated in OC cells.
In our previous study [Bodmer et al., 2002], FasL was
observed on supporting cells in the OC of sections from
animals undergoing a cochlear secondary immune re-
sponse. No labeling was observed in hair cells. In the
present study, we did not identify the OC cells labeled
with anti-FasL antibody. However, the OC consists of
hair cells and supporting cells. The fact that virtually all
cells showed changes in FasL distribution, and that hair
cells survive poorly in dispersed tissue culture, suggests
that the changes observed in the present study occurred in
supporting cells.
The function of FasL translocation to OC cell mem-
branes is not clear. It is possible that FasL serves to pro-
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tect the hair cells of the OC from immune and inflamma-
tory cells bearing Fas on their surfaces. A similar function
for FasL has been proposed to occur in the anterior cham-
ber of the eye [Griffith et al., 1996]. In the OC, expression
of FasL on supporting cells could serve to protect the hair
cells, which are surrounded by supporting cells. Relevant
to this hypothesis, mice deficient in Fas have been pro-
posed to be a model for autoimmune inner ear damage
[Trune et al., 1989]. Alternatively, FasL could participate
in the death of OC cells in response to stress. Additional
studies on the effects of FasL in the inner ear would be
required to address this issue.
Although real-time PCR is a very sensitive technique,
the method used to isolate sufficient mRNA from co-
chlear tissue is critical for successful downstream applica-
tions. We found that isolation of mRNA from cochlear
tissue with magnetic microbeads provides enough starting
material for successful reverse transcription and subse-
quent real-time PCR analysis. However, it is essential that
mRNA be released from the beads prior to the reverse
transcription and real-time PCR analysis, as we found
that the beads interfere with the optical detection system
of real-time PCR. The levels of mRNA present in our
original samples cannot be determined, since the efficien-
cies of mRNA extraction and reverse transcription are not
known. However, it seems reasonable to assume the effi-
ciencies were similar in the two experimental conditions.
It should be noted that one value obtained for ß-actin in a
control OC was very low (fig. 3a). There was no reason to
exclude these data, and so they were left in the study.
However, analysis without this sample yielded the same
results.
Real-time PCR has been used to assess gene expression
in cells of vestibular origin [Uno et al., 2000, 2002]; how-
ever, to our knowledge this is the first report of the appli-
cation of real-time PCR analysis to cells of the cochlea.
The present study demonstrates that it is possible to
obtain sufficient mRNA for real-time PCR from cochlear
tissue, and it confirms the utility of the technique for
cochlear cells.
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